Shanghai Pharmaceuticals Holding Co Ltd 2022 SR
The report highlights Shanghai Pharma's 2022 sustainability efforts, focusing on innovation in rare disease treatments and the establishment of the Shanghai Biomedical Frontier Industrial Innovation Center. The company committed to achieving carbon peak for its industrial sector by 2030 and implemented over 70 energy-saving projects. Socially, it invested 50.19 million RMB in public welfare and 4.02 million RMB in rural revitalization. It also maintained a strong focus on quality management and employee development, earning recognition as a 'China Exemplary Employer.'
Company: Shanghai Pharmaceuticals Holding Co Ltd
Sector: Manufacturing
Country: China
Year: 2022
Type: SR
Pages: 77
Back to company
Shanghai Pharmaceuticals Holding Co Ltd
Sustainability Report And Environmental, Social And Governance Report
The report highlights Shanghai Pharma's 2022 sustainability efforts, focusing on innovation in rare disease treatments and the establishment of the Shanghai Biomedical Frontier Industrial Innovation Center. The company committed to achieving carbon peak for its industrial sector by 2030 and implemented over 70 energy-saving projects. Socially, it invested 50.19 million RMB in public welfare and 4.02 million RMB in rural revitalization. It also maintained a strong focus on quality management and employee development, earning recognition as a 'China Exemplary Employer.'
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English, Chinese
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Workplace Fatalities
Employees